These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2360247)

  • 61. A new proposal for the mechanism of cyclosporine A nephrotoxicity. Inhibition of renal microsomal protein chain elongation following in vivo cyclosporine A.
    Buss WC; Stepanek J; Bennett WM
    Biochem Pharmacol; 1989 Nov; 38(22):4085-93. PubMed ID: 2597185
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Long-term comparison of rat model of chronic allograft rejection of orthotopic small bowel transplantation induced by cyclosporine versus tacrolimus.
    Li Y; Zhu Y; Wang J; Wei W; Wu B; Li J
    Transplant Proc; 2013 Jun; 45(5):1811-5. PubMed ID: 23769050
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The effect of combination therapy with EPC-K1 and low-dose cyclosporine to pulmonary allograft after rat lung transplantation.
    Udaka T; Misao T; Aoe M; Date H; Andou A; Shimizu N
    J Heart Lung Transplant; 1997 Aug; 16(8):839-45. PubMed ID: 9286776
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prophylaxis of acute renal allograft rejection using FTY720 in combination with subtherapeutic doses of cyclosporine.
    Troncoso P; Stepkowski SM; Wang ME; Qu X; Chueh SC; Clark J; Kahan BD
    Transplantation; 1999 Jan; 67(1):145-51. PubMed ID: 9921811
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Optimal cyclosporine plasma levels decline with time of therapy.
    Klintmalm G; Säwe J; von Bahr C; Ringdén O; Lundgren G; Wilczek H; Tydén G; Groth CG
    Transplant Proc; 1984 Oct; 16(5):1208-11. PubMed ID: 6385380
    [TBL] [Abstract][Full Text] [Related]  

  • 66. 1alpha,25-dihydroxyvitamin D3 shows strong and additive immunomodulatory effects with cyclosporine A in rat renal allotransplants.
    Redaelli CA; Wagner M; Günter-Duwe D; Tian YH; Stahel PF; Mazzucchelli L; Schmid RA; Schilling MK
    Kidney Int; 2002 Jan; 61(1):288-96. PubMed ID: 11786111
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Presensitization accelerates chronic allograft rejection in a heterotopic rat tracheal allograft model with immunosuppression.
    Okumoto T; Yamane M; Sano Y; Aoe M; Date H; Shimizu N
    Transpl Immunol; 2007 Jun; 17(4):249-54. PubMed ID: 17493527
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Immunosuppression with aerosolized cyclosporine for prevention of lung rejection in a rat model.
    Zenati M; Duncan AJ; Burckart GJ; Schaper M; Yousem SA; Griffith BP; Casarotto D
    Eur J Cardiothorac Surg; 1991; 5(5):266-71; discussion 272. PubMed ID: 1859667
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Interleukin 2 receptor in rat heart allograft rejection.
    Bouchot O; Anegon I; Romaniuk A; Jacques Y; Paineau J; Soulillou JP
    Transplantation; 1989 Dec; 48(6):918-22. PubMed ID: 2595779
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Functional monitors of rejection in small intestinal transplants.
    Nordgren S; Cohen Z; Mackenzie R; Finkelstein D; Greenberg GR; Langer B
    Am J Surg; 1984 Jan; 147(1):152-8. PubMed ID: 6691542
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Modulation of accelerated rejection of cardiac allografts in sensitized rats by anti-interleukin 2 receptor monoclonal antibody and cyclosporine therapy.
    Kupiec-Weglinski JW; Sablinski T; Hancock WW; Di Stefano R; Mariani G; Mix CT; Tilney NL
    Transplantation; 1991 Feb; 51(2):300-5. PubMed ID: 1825240
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Renal allograft rejection, lymphocyte infiltration, and de novo donor-specific antibodies in a novel model of non-adherence to immunosuppressive therapy.
    Kühne L; Jung B; Poth H; Schuster A; Wurm S; Ruemmele P; Banas B; Bergler T
    BMC Immunol; 2017 Dec; 18(1):52. PubMed ID: 29258420
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Exploitation of the continuum between early ischemia/reperfusion injury and host alloresponsiveness: indefinite kidney allograft survival by treatment with a soluble P-selectin ligand and low-dose cyclosporine in combination.
    Kusaka M; Zandi-Nejad K; Kato S; Beato F; Nagano H; Shaw GD; Tilney NL
    Transplantation; 1999 May; 67(9):1255-61. PubMed ID: 10342318
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Oxidative stress-mediated renal dysfunction by cyclosporine A in rats: attenuation by trimetazidine.
    Satyanarayana PS; Chopra K
    Ren Fail; 2002 May; 24(3):259-74. PubMed ID: 12166693
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A short course of cyclosporine immunosuppression inhibits rejection but not tolerance of rat liver allografts.
    Huang WH; Yan Y; De Boer B; Bishop GA; House AK
    Transplantation; 2003 Feb; 75(3):368-74. PubMed ID: 12589161
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A role for leukotrienes in cyclosporine nephrotoxicity.
    Butterly DW; Spurney RF; Ruiz P; Griffiths R; Albrightson C; Coffman TM
    Kidney Int; 2000 Jun; 57(6):2586-93. PubMed ID: 10844628
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Budesonide, a locally acting steroid, prevents graft rejection in a rat model of intestinal transplantation.
    Ozcay N; Fryer J; Grant D; Freeman D; Garcia B; Zhong R
    Transplantation; 1997 May; 63(9):1220-5. PubMed ID: 9158013
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Analysis of functional renal allograft tolerance with single-dose rapamycin based induction immunosuppression.
    Goggins WC; Fisher RA; Dattilo JB; Cohen DS; Tawes JW; Dattilo MP; Babcock GF; Frede SE; Wakely PE; Posner MP
    Transplantation; 1997 Jan; 63(2):310-4. PubMed ID: 9020336
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A comparative toxicological study of cyclosporine and Nva2-cyclosporine in Sprague-Dawley rats.
    Duncan JI; Thomson AW; Simpson JG; Davidson RJ; Whiting PH
    Transplantation; 1986 Oct; 42(4):395-9. PubMed ID: 3765053
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comparison of the effects of cyclosporin G (OG37-325), cyclosporin A, and their metabolites on the release of endothelin and prostacyclin from primary renal and aortic endothelial cell lines.
    Langman LJ; Yatscoff RW
    Ther Drug Monit; 1994 Oct; 16(5):450-7. PubMed ID: 7846742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.